Apovomin 3 mg/ml sol. inj. s.c. flac. Belgique - français - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

apovomin 3 mg/ml sol. inj. s.c. flac.

dechra regulatory b.v. - chlorhydrate d'apomorphine 3 mg/ml - eq. apomorphine 2,56 mg/ml - solution injectable - 3 mg/ml - chlorhydrate d'apomorphine 3 mg/ml - apomorphine - chien

Emedog 1 mg/ml sol. inj. s.c. amp. Belgique - français - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

emedog 1 mg/ml sol. inj. s.c. amp.

domes pharma - chlorhydrate d'apomorphine 1,17 mg/ml - eq. apomorphine 1 mg/ml - solution injectable - 1 mg/ml - chlorhydrate d'apomorphine 1.17 mg/ml - apomorphine - chien

APOKINON 10 mg/ml, solution injectable (S.C.) France - français - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

apokinon 10 mg/ml, solution injectable (s.c.)

laboratoire aguettant - chlorhydrate d'apomorphine - solution - 10 mg - composition pour 1 ml > chlorhydrate d'apomorphine : 10 mg - antiparkinsonien dopaminergique

Sitagliptin / Metformin hydrochloride Mylan Union européenne - français - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabète sucré, type 2 - les médicaments utilisés dans le diabète - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. triple thérapie de combinaison) en complément d'un régime alimentaire et l'exercice chez les patients insuffisamment contrôlés sur leur dose maximale tolérée de metformine et une sulphonylurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Vildagliptin / Metformin hydrochloride Accord Union européenne - français - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabète sucré, type 2 - les médicaments utilisés dans le diabète - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 et 5. 1 pour les données disponibles sur différentes combinaisons).

APOGO 10 mg/ml, solution injectable/pour perfusion France - français - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

apogo 10 mg/ml, solution injectable/pour perfusion

britannia pharmaceuticals limited - chlorhydrate d'apomorphine - solution - 10 mg - composition pour 1 ml > chlorhydrate d'apomorphine : 10 mg - agonistes dopaminergiques

APOGO 5 mg/ml, solution pour perfusion en seringue préremplie France - français - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

apogo 5 mg/ml, solution pour perfusion en seringue préremplie

britannia pharmaceuticals limited - chlorhydrate d'apomorphine - solution - 5 mg - composition pour 1 ml > chlorhydrate d'apomorphine : 5 mg - agonistes dopaminergiques

Sitagliptin / Metformin hydrochloride Accord Union européenne - français - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabète sucré, type 2 - les médicaments utilisés dans le diabète - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. triple thérapie de combinaison) en complément d'un régime alimentaire et l'exercice chez les patients insuffisamment contrôlés sur leur dose maximale tolérée de metformine et une sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Ambroxol Hydrochloride Unither Pharmaceuticals 30 mg/5 ml sol. buv. Belgique - français - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

ambroxol hydrochloride unither pharmaceuticals 30 mg/5 ml sol. buv.

unither pharmaceuticals s.a. - chlorhydrate d'ambroxol 6 mg/ml - solution buvable - 30 mg/5 ml - chlorhydrate d'ambroxol 6 mg/ml - ambroxol

Diphenhydramine Hydrochloride Omega Pharma 50 mg comp. Belgique - français - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

diphenhydramine hydrochloride omega pharma 50 mg comp.

omega pharma belgium sa-nv - chlorhydrate de diphénhydramine 50 mg - eq. diphénhydramine 43,8 mg - comprimé - 50 mg - chlorhydrate de diphénhydramine 50 mg - diphenhydramine